H

Hepion Pharmaceuticals

D
HEPA
USD
-0.03
(-4.6154%)
Market Closed
190.000
حجم التداول
-11.43
الربح لكل سهم
-
العائد الربحي
-0.096724
P/E
3,595,458.12
حجم السوق
اليوم
-4.6154%
1 اسبوع
-4.615%
1 شهر
-2.378%
6 اشهر
-55.072%
12 اشهر
-83.938%
بداية السنة
-80.864%
كل الوقت
0%

Title:
Hepion Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
هل تحتاج مساعدة او لديك استفسار؟